Global Artificial Pancreas Device Systems Market - Industry Trends and Forecast to 2028

Market Analysis and Insights of Artificial Pancreas Systems Market

Data Bridge Market Research analyses that the artificial pancreas systems market will exhibit a CAGR of around 8.40% for the forecast period of 2021-2028. Rising demand of remote monitoring applications, and home care setting devices along with rising government initiatives in clinical research are the major factors attributable to the growth of the artificial pancreas systems market.

Pancreas is an organ in the body that is responsible for secreting and producing digestive juices. Pancreases are surrounded, by small intestine, spleen, stomach, liver and gall bladder and produce enzymes such as trypsin and chymotrypsin. These enzymes digest proteins, carbohydrates, and fats. Artificial pancreas system is a technology that screens the glucose level in blood and provides substitute endocrine functionality of pancreas. It not only monitors the level of glucose in the body but also automatically adjust the delivery of insulin to reduce high blood glucose levels. In other words, they perform the same functions as that or normal pancreas.

Rising prevalence of diabetes is one of the major factors fostering the growth of artificial pancreas systems market. Rising expenditure for research and development activities and rising personal disposable income are some other indirect market growth determinants. Rising technological advancements in the healthcare sector will further generate lucrative market growth opportunities. Rising medical tourism is also an important market growth promoter.

However, high costs associated with installing the equipment will act as a major market growth restraint. Unfavourable reimbursement policies especially in the developing economies will further pose challenges for the market growth. Dearth of skilled professionals or trained expertise will further derail the market growth rate.

This artificial pancreas systems market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on artificial pancreas systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Artificial Pancreas Systems Market Scope and Market Size

The artificial pancreas systems market is segmented on the basis of device and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• Based on device, the global artificial pancreas systems market has been divided into threshold suspended device system, CTR system and CTT system.
• Based on the end user, the artificial pancreas systems market has been segmented as hospitals, clinics, home care, ambulatory centre and others.

Artificial Pancreas Systems Market Country Level Analysis

The artificial pancreas systems market is analysed and market size insights and trends are provided by country, device and end users as referenced above.

The countries covered in the artificial pancreas systems market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the artificial pancreas systems market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the prevailing sophisticated level of healthcare facilities coupled with the rising advancement in the technology involved in healthcare sector. Concentration of major key players in this region is also fostering the growth of the region in the global artificial pancreas systems market. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to the rising prevalence of diabetes coupled with increased expenditure on healthcare infrastructure.

The country section of the artificial pancreas systems market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Artificial pancreas systems market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital health technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the artificial pancreas systems market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Artificial Pancreas Systems Market Share Analysis

The artificial pancreas systems market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to artificial pancreas systems market.

The major players covered in the artificial pancreas systems market report are Medtronic, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd, Insulet Corporation., Tandem Diabetes Care, Inc., Beta Bionics, Inc., BIGFOOT BIOMEDICAL, INC., Glooko, Inc., Teladoc Health, Inc., Verily Life Sciences LLC, ViaCyte, Inc., Vertex Pharmaceuticals Incorporated, Diabeloop SA., Admetsys., Defymed, Pancreum, Inc., Dexcom, Inc., JDRF, TypeZero Technologies, Inc, and Animas Corporation among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-10706